Lipocine to present at the cantor fitzgerald global healthcare conference

Salt lake city , sept. 19, 2023 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company focused on treating central nervous system (cns) disorders, today announced that dr. mahesh patel, president and chief executive officer, will present and meet with investors at the 2023 cantor fitzgerald global healthcare conference to take place september 26th to september 28th in new york city.
LPCN Ratings Summary
LPCN Quant Ranking